Videos

New York Huaqi Bioengineering | Lili Xu, CEO

New York Huaqi Bioengineering is developing products to preserve and enhance the health and functionality of donated human organs.

GreenBone Ortho | Alastair Clemow, President

Bone regenerating, load-bearing implants to treat severe fractures and conditions such as trauma and tumors that result in extensive bone loss.

Embody | Jeff Conroy, Embody

Collagen-based implants for the treatment of tendon and ligament injuries.

Acorn BioLabs | Drew Taylor, CEO

Acorn is developing a non-insaive cryopreservation solution for the preservation of healthy follicle cells for use in cellular treatments.

Exciton Pharma | Carla Spina, CSO

Exciton Pharma Corp (EPC) is a late-stage pre-clinical, multi-asset biotech company developing first-in-class compounds for the inclusive treatment of infection and skin diseases.

Sparta Biomedical | Dushyanth Surakanti, CEO

The first osseointegrative biomimetic knee cartilage implant.

Rapid Nexus | Dr. Margaret Kalmeta, CEO & Founder

Rapid Nexus has developed a first of its kind nanotechnology wound dressing, along with devices that accelerate healing, to rapidly close chronic non-healing wounds.

Access Vascular | James Biggins, President & CEO

Access Vascular is developing a suite of venous access devices that use our novel, patented biomaterial which is designed to prevent the most common and costly complications in venous access.

Carevature | Dennis Farrell, President & CEO

Carevature Medical develops advanced orthopedic solutions to address limitations of current surgical solutions.

restor3d | Ken Gall, CEO

By combining expertise in 3D printing with advanced biomaterials and artificial intelligence, restor3d is creating patient-specific orthopedic implants to reconstruct and repair the human body.

Leonhardt Ventures | Howard Leonhardt, CEO

The company is focused on organ regeneration & recovery innovations based on the convergence of bioelectrics & biologics.

Nanochon | Ben Holmes, CEO

Nanochon is applying novel materials to replicate bone and cartilage, and high-end 3D printing to create an implant which can permanently repair debilitating joint injuries.

ATRO Medical | Jan Hunik, CEO

ATRO Medical is developing Trammpolin, a prosthetic meniscus made of anatomically shaped polymer for the replacement of damaged menisci.